Literature DB >> 35230471

The role of cerebellar damage in explaining disability and cognition in multiple sclerosis phenotypes: a multiparametric MRI study.

Raffaello Bonacchi1,2, Alessandro Meani1, Elisabetta Pagani1, Olga Marchesi1, Massimo Filippi1,2,3,4,5, Maria A Rocca6,7,8.   

Abstract

BACKGROUND: Cerebellar involvement is not comprehensively studied from an MRI point of view in multiple sclerosis (MS). We aimed to quantify cerebellar damage and identify predictors of physical disability and cognitive dysfunction in MS patients, and to characterize patients with cerebellar disability.
METHODS: In this prospective study, 164 (89 relapsing-remitting and 75 progressive) MS patients and 53 healthy controls were enrolled. Subjects underwent 3T MRI with sequences for assessing lesions and atrophy in cerebellum, supratentorial brain, brainstem and cervical cord. Cerebellar peduncle diffusion-tensor metrics were also derived. Random forest models identified MRI predictors of Expanded Disability Status Scale (EDSS) score and cognition z-score. Hierarchical clustering was applied on MRI metrics in patients with cerebellar disability.
RESULTS: In MS patients, predictors of higher EDSS score (out-of-bag-R2 = 0.83) were: lower cord grey matter (GM) and global areas, brain volume, GM volume (GMV), cortical GMV, cerebellum lobules I-IV and vermis GMV; and higher cord GM and brainstem lesion volume (LV). Predictors of lower cognition z-score (out-of-bag-R2 = 0.25) were: higher supratentorial and superior cerebellar peduncle LV; and lower brain, thalamus and basal ganglia volumes, GMV, cerebellum lobule VIIIb and Crus II GMV. In patients with cerebellar disability, we found three clusters with homogenous MRI metrics: patients with high brain lesion volumes (including cerebellar peduncles), those with marked cerebellum GM atrophy and patients with severe cord damage.
CONCLUSIONS: Damage to cerebellum GM and connecting structures has a relevant role in explaining cognitive dysfunction and physical disability in MS. Data-driven MRI clustering might improve our knowledge of MRI-clinical correlations.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Cerebellum; DWI; MRI; Multiple sclerosis; Volumetric MRI

Mesh:

Year:  2022        PMID: 35230471     DOI: 10.1007/s00415-022-11021-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

1.  Permutation importance: a corrected feature importance measure.

Authors:  André Altmann; Laura Toloşi; Oliver Sander; Thomas Lengauer
Journal:  Bioinformatics       Date:  2010-04-12       Impact factor: 6.937

2.  Cerebellar lobule atrophy and disability in progressive MS.

Authors:  Sirio Cocozza; Maria Petracca; Enricomaria Mormina; Korhan Buyukturkoglu; Kornelius Podranski; Monika M Heinig; Giuseppe Pontillo; Camilla Russo; Enrico Tedeschi; Cinzia Valeria Russo; Teresa Costabile; Roberta Lanzillo; Asaff Harel; Sylvia Klineova; Aaron Miller; Arturo Brunetti; Vincenzo Brescia Morra; Fred Lublin; Matilde Inglese
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-08-26       Impact factor: 10.154

Review 3.  Progressive multiple sclerosis: from pathogenic mechanisms to treatment.

Authors:  Jorge Correale; María I Gaitán; María C Ysrraelit; Marcela P Fiol
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

4.  Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis.

Authors:  Raffaello Bonacchi; Elisabetta Pagani; Alessandro Meani; Laura Cacciaguerra; Paolo Preziosa; Ermelinda De Meo; Massimo Filippi; Maria A Rocca
Journal:  Radiology       Date:  2020-06-23       Impact factor: 11.105

5.  Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosis.

Authors:  Sara Cirillo; Maria A Rocca; Angelo Ghezzi; Paola Valsasina; Lucia Moiola; Pierangelo Veggiotti; Maria P Amato; Giancarlo Comi; Andrea Falini; Massimo Filippi
Journal:  Mult Scler       Date:  2015-07-10       Impact factor: 6.312

6.  Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis.

Authors:  Massimiliano Calabrese; Irene Mattisi; Francesca Rinaldi; Alice Favaretto; Matteo Atzori; Valentina Bernardi; Luigi Barachino; Chiara Romualdi; Luciano Rinaldi; Paola Perini; Paolo Gallo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-12-03       Impact factor: 10.154

7.  Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy.

Authors:  R H B Benedict; D Ramasamy; F Munschauer; B Weinstock-Guttman; R Zivadinov
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-10-01       Impact factor: 10.154

8.  MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.

Authors:  V M Anderson; L K Fisniku; D R Altmann; A J Thompson; D H Miller
Journal:  Mult Scler       Date:  2009-05-22       Impact factor: 6.312

9.  Prevalence and patterns of subclinical motor and cognitive impairments in non-disabled individuals with early multiple sclerosis: A multicenter cross-sectional study.

Authors:  Davide Cattaneo; Elisa Gervasoni; Denise Anastasi; Rachele Di Giovanni; Giampaolo Brichetto; Ilaria Carpinella; Paola Cavalla; Paolo Confalonieri; Elisabetta Groppo; Luca Prosperini; Andrea Tacchino; Marco Rovaris; Claudio Solaro
Journal:  Ann Phys Rehabil Med       Date:  2021-11-12

10.  A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis.

Authors:  V M Anderson; C A M Wheeler-Kingshott; K Abdel-Aziz; D H Miller; A Toosy; A J Thompson; O Ciccarelli
Journal:  Mult Scler       Date:  2011-04-20       Impact factor: 6.312

View more
  1 in total

1.  A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis.

Authors:  Dejan Jakimovski; Katelyn S Kavak; Karen Zakalik; Lacey Bromley; Osman Ozel; Natasha Qutab; Svetlana P Eckert; Channa Kolb; Bianca Weinstock-Guttman
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.